Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Perfect..having confidence now.
But why he is borrow more than he owns to ChemDiv?
Ok payments will be record on those financial statements. Great! Tks!
"Every 3 Months we get SEC auditor reviewed financial statements made public."
How we will know as shareholders, if he is making payments each months (beginning March 2022)?
Did you miss the action yesterday?
8k out, etc...
Crazy Friday!
Really don't know how next week will be!
"But a little poutine.."
Hahahahaha! It's a poutine story!
Next time I'll eat a poutine, I will laugh alone! :)
Mr Koss achieve great accomplishments in short time, bravo!..but I am wondering:
On Sept 17, RB issued a promissary note of $1,500,000. ($1,390,000. left after.. bla..bla..bla…)
Sept 21 RB paid 800k to ChemDiv Inc.
Why issue a p. note for the amount of $1,500,000 if RB own to ChemDiv Inc only 800K?
Following Default by RG, p. note become convertible in common shares.
Why RB would pay capital/interest till July 2022 if there is default to pay, he can pay the bill w common shares? It might be tempting to stop paying int/cap and pay w c. shares.
How we will know if he is making payment on the 17th of each month?
8k interesting for long term.
It's a good question, but I am not worry.
Buyers will be back soon.
8k was really interesting and give confidence to shareholders.
Probably some wants price down.
Dumpers will leave I guess, I hope so.
It's a good question..
Maybe if one day there is bad news, it will goes up! LOL
"Its raining gold nuggets."
I like the picture! :)
Buyers will be back...time to buy anyway!
After I bought last April, I was not a believer because some bad comments about Mr Koos.
I sold (at that time, to my point of view, there were too much red flags), so I sold higher a bit, and finally I bought again at lower price and add more once in a while.
I am happy I was not influence anymore by some negatives comments.
Yes, I am impress!
He is also looking to achieve other interesting goal.
I am sure he will succeed considering huge progress already done in short time.
Bravo! Congratulation!
For newbie:
OTCQB
The middle tier of OTC Markets – OTCQB – is known as The Venture Market. Companies that trade on this tier are in their early stages, and therefore, may not be able to meet the financial or regulatory requirements required by the exchanges or OTCQX.
To be eligible for OTCQB, companies must be current in their financial reporting, undergo an annual verification and management certification process, and have a bid price of at least $0.01. They also cannot be in bankruptcy. Over 900 companies trade on the OTCQB Market.
OTCQB is like Nasdaq?
I also like "Progress to date".
Huge achievment!
Item 1.01 Entry into a Material Definitive Agreement.
On September 17,2021 Regen Biopharma, Inc. ( the “Company”) issued a promissory note in the principal amount of $1,500,000 ( “Note”) of which $75,000 was retained by the Holder through an Original Issue Discount for due diligence and origination related to this transaction and Thirty-five Thousand Dollars $35,000 was remitted by the Holder, at the instance and on behalf of the Company, directly to Holder’s counsel for documentation preparation fees resulting in net consideration paid to the Company of $1,390,000.
The Note carries “Guaranteed Interest” on the principal amount at the rate of 5% per annum for the ten-month term of this Note for an aggregate Guaranteed Interest $62,500 all of which Guaranteed Interest shall be deemed earned as of September 17, 2021.
The Principal Amount and the Guaranteed Interest shall be due and payable in five equal monthly payments of $312,500 commencing on March 17, 2022 and continuing on the 17th day of each month thereafter until paid in full not later than July 18, 2022 (the “Maturity Date”).
Solely following an Event of Default (as such term is defined in the Note) the Note shall become convertible, in whole or in part, into shares of Common Stock at the option of the Holder. The conversion price of the Note is 90% of the lowest per-share Trading Price per share. Trading Price is defined as the lowest daily VWAP for the 20 Trading Days preceding a Conversion Date. VWAP is defined as the dollar volume-weighted average price for the common shares as reported by Bloomberg.
The foregoing description of the abovementioned Agreement is not complete and is qualified in its entirety by reference to the text of the abovementioned agreement , which is attached to this Current Report on Form 8-K as Exhibit 10.1 and incorporated in this Item 1.01 by reference.
Item 8.01
On September 21, 2021 the Company paid $800,000 to ChemDiv, Inc. pursuant to that Settlement and Release Agreement (“Settlement And Release Agreement”) entered into by and between CHEMDIV, INC. ("ChemDiv"), REGEN BIOPHARMA, INC. ("Regen"), ZANDER THERAPEUTICS, INC., and DAVID KOOS ("Koos") on September 15, 2021.
The text of the abovementioned Settlement And Release Agreement is attached to this Current Report on Form 8-K as Exhibit 10.2 and incorporated in this Item 8.01 by reference.
Item 8.01
On September 24th 2021 the Company’s Chairman and Chief Executive Officer released the following update to the shareholders of the Company
REGEN BIOPHARMA, INC.
MESSAGE TO THE SHAREHOLDERS FROM THE CHAIRMAN AND CHIEF EXECUTIVE OFFICER
When I returned to Regen on March 23, 2021 in order to serve as Chairman and Chief Executive Officer I found myself at the helm of a company on the verge of collapse. We were behind in bills, at risk of losing patent protection on valuable IP, and delinquent in our SEC filing obligations. Worse of all we were being sued by our Contract Research Organization in a complaint seeking damages of $1,200,000 which also threatened our ownership rights to valuable intellectual property. The progress we have achieved since my return has been substantial and yet is dwarfed by what I believe can be achieved in the months to come.
PROGRESS TO DATE
Since my return the Company has:
1) Become current in its SEC filing obligations eliminating the risk that the public trading market for both the common and Series A preferred shares would disappear.
2) Paid amounts owed to essential vendors such as the Company’s patent attorney in order that important business relationships could resume unimpeded
3) Revived applications pertaining to vital intellectual property deemed abandoned by the US Patent and Trademark Office
4) Obtained financing in the net amount of $1,390,000 through the issuance of a Promissory Note which would become convertible into stock ONLY in the event the Company defaults. So long as the Company is timely in payments and otherwise complies with the terms and conditions of the Note this Note MAY NOT be converted.
5) Settled the lawsuit brought by ChemDiv, Inc., our Contract Research Organization, for the sum of $800,000 which was paid to ChemDiv on September 21, 2021.
6) Been issued several patents
7) Entered into two non-related party licensing agreement resulting in non-related party revenue of $1,905,000 being recognized in the quarter ended June 30, 2021. These licensing agreements pertain to mRNA and our checkpoint NR2F6.
SHORT TERM GOALS
During the coming months I shall endeavor to achieve the following milestones:
1) Settle all outstanding convertible notes payable in order that the Company will have no convertible instruments outstanding.
2) Hire a Chief Scientific Officer
3) Seek out and enter into alliances, co-development agreements and additional licensing agreements with regard to our proprietary mRNA and NR2F6 portfolios.
4) Obtain OTCQB listing for our securities on the OTC Market.
5) Establish a social media presence in order to more easily provide updates to our shareholders, the investment community, the scientific community and the public at large.
Thank you for your past and continued patience as we move the Company forward. I look forward to receiving shareholder input and can be reached at david.koos@regenbiopharma.com.
Sincerely,
David Koos
"Story of my life. Another no show."
Your funny! :)
Sorry I should told you that I am in relation since 1977 (common law partner)!
No jealousy between us, I "talk" with everyone!
(Yep "Law" that's the right word.."opinions"!)
Also tks to all other with experience on that kind of market!
Thanks "Law" for your (not advice..how I can say that?) your info, up to date?
Anyway thanks!
It's probably appreciated by all on this board.
Bravo! Big applaud RGBP!
But it's better than Monday to Thursday (the calm before the storm)!
I am happy with that increase! :)
At least it's moving up!
Patience...
As one on the board suggest to me: go eat a poutine, it will settle your nerve!
Interesting..
Thanks for your testimony.
Timing..timing!
Have a happy "Happy hours"!
Chin..chin!
"...You never now what will happen and when is going to take off..."
That's why I don't sell any.
I am to scare to regret the move.
Patience...
And new "GROUPON" are entering! LOL
Great finish for the day!
I complained couple of hours too early.
Patience.....
Should be fun tomorrow!
Good one...hahahahahaha!!!
In fact I am generally patient (but not this week)..I bought some stock in Oct 2018, sold with a nice profit 2 years later.
Yep..nice song..waiting for the "Blue Sky Express"! lalalalalala!
Ok. Waiting for the Blue Sky Express.
I am returning in "mute" mode!
Just need to vent a bit.
We need a group therapy for the fighter and impatient one! LOL
I am impatient, but not to the point to sale shares...any shares!
Maybe in 2022, not before.
But the week begin at .0426 and all week ..going down, low volume.
Hopefully good news will come soon...Sept 30 is coming.
I hope that a witch with better proportion will appear before Halloween!
I am getting impatient..dull week!
Group therapy tonight! It's ok, just funny! Lol
ah..I see..tks!
If there is a buyout and it turns in cash, RGBP shares will be delisted same day?
I hope your right... hold tight!
(Oct 2017)
Regen BioPharma, Inc. Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board (BAB)
https://www.prnewswire.com/news-releases/regen-biopharma-inc-announces-former-eli-lilly-executive-and-current-cvs-board-member-will-lead-newly-formed-business-advisory-board-bab-654072053.html
No, I am looking at "Trades" only.
Level 2 is for membership, I am not.
Back to business..more buyers than sellers!
Of course!
Talking food is much fun! LOL
I know, they used beef instead of veal.
First recipe I found..anyway I prefer Milanaise veal!